Despite advances in diagnostic and therapeutic technologies for cardiovascular diseases
(CVDs), it remains a leading cause of mortality and morbidity worldwide. This underscores …

Globally, cardiovascular diseases (CVDs) are the leading cause of death and disability.
While there are many therapeutic alternatives available for the management of CVDs, the …

Drug‐coated balloons (DCB) intervention is an important approach for the treatment of
atherosclerosis (AS). However, this therapeutic approach has the drawbacks of poor drug …

2D ultrafine nanomaterials today represent an emerging class of materials with very
promising properties for a wide variety of applications. Biomedical fields have experienced …

In the pursuit of alternative and less invasive medical treatments, magnetic nanoparticles
(NPs) have gained significant relevance. Iron carbides NPs stand out for their higher …

The high mortality rate caused by atherosclerosis makes it necessary to constantly search
for new and better treatments. In previous reports, chemically modified carbon-coated iron …

As-produced carbon nanotubes contain impurities which can dominate the properties of the
material and are thus undesired. Herein we present a multi-step purification treatment that …

Atherosclerosis is a severe cardiovascular disease followed by the accumulation of
atherosclerotic plaques within the lumen of blood vessels resulting in reduced blood flow …

The use of chemically modified nanocomposites for atherosclerotic plaques can open up
new opportunities for studying their effect on changing the structure of the plaque itself. It …

High mortality associated with atherosclerosis necessitates the development of novel
strategies for its treatment. Despite the widespread use and success of lipid-reducing drugs …